0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Alanine Aminotransferase Levels: What's Normal?

Marshall M. Kaplan, MD
[+] Article and Author Information

Tufts–New England Medical Center; Boston, MA 02111


Requests for Single Reprints: Marshall M. Kaplan, MD, Tufts–New England Medical Center, 750 Washington Street, Box 233, Boston, MA 02111; e-mail, mkaplan@lifespan.org.


Ann Intern Med. 2002;137(1):49-51. doi:10.7326/0003-4819-137-1-200207020-00012
Text Size: A A A

Alanine aminotransferase (ALT), a sensitive indicator of liver cell injury, has been used to identify patients with liver disease for almost 50 years (1). This cytosolic enzyme, which is found in many organs, catalyzes the transfer of the α-amino group from alanine to α-ketoglutaric acid (2). Alanine aminotransferase levels are particularly high in the liver. For detection of liver diseases, ALT is thought to be a more specific indicator than aspartate aminotransferase, an enzyme found in cytosol and mitochondria (3). Serum levels of ALT normally are low—167 to 667 nkat/L (10 to 40 U/L) in most laboratories; however, normal values may vary greatly among laboratories. Elevated serum ALT levels help identify many types of liver diseases in patients and were widely used in the 1980s to screen blood donors for non-A, non-B hepatitis. Any type of liver cell injury can modestly increase ALT levels. Values up to 5000 nkat/L (300 U/L) are considered nonspecific. Marked elevations—that is, ALT levels greater than 8350 nkat/L (500 U/L)—occur most often in persons with diseases that affect primarily hepatocytes, such as viral hepatitis, ischemic liver injury (shock liver), and toxin-induced liver damage. Despite the association between greatly elevated ALT levels and hepatocellular diseases, the absolute height of the ALT elevation does not correlate with the extent of liver cell damage (4). Accordingly, the absolute ALT elevation is of little prognostic value. Currently, measurement of serum ALT levels is the most frequently used test to identify patients with liver diseases.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)